← Back to Search

Work-Focused Program for Substance Use Disorders

N/A
Recruiting
Led By Joanna M. Fiszdon, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must be 18 years of age and older
Must be competent to give written informed consent and HIPAA authorization
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will test whether work-focused programs can help Veterans in early recovery from substance use disorder achieve sobriety and other better clinical outcomes.

Who is the study for?
This trial is for Veterans diagnosed with any Substance Use Disorder (SUD) such as opioids or alcohol, who are enrolled in VACHS substance use treatment and are within 30 days of detoxification. Participants must be over 18, able to consent, and not planning to relocate or likely to be incarcerated during the study.Check my eligibility
What is being tested?
The trial is testing if work-focused programs can help improve sobriety and overall functioning in Veterans recovering from SUDs. It randomly assigns participants to either receive a referral for these programs or continue with their usual treatment without additional work focus.See study design
What are the potential side effects?
Since this trial involves referral to therapeutic work activities rather than medication, traditional side effects like those seen with drugs aren't expected. However, there may be stress or emotional impacts associated with participating in work-focused therapy.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am able to understand and sign the consent form.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical Global Impression
percent days abstinent
Secondary outcome measures
change from baseline in BASIS-24
change from baseline in New General Self-Efficacy Scale
change from baseline in Rosenberg self-esteem scale
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: treatment as usual plus referral to work focused programExperimental Treatment2 Interventions
usual substance use treatment plus referral to a competitive or non-competitive work-focused program
Group II: treatment as usualActive Control1 Intervention
usual substance use treatment

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,463 Total Patients Enrolled
Joanna M. Fiszdon, PhDPrincipal InvestigatorVA Connecticut Healthcare System West Haven Campus, West Haven, CT
2 Previous Clinical Trials
234 Total Patients Enrolled

Media Library

treatment as usual Clinical Trial Eligibility Overview. Trial Name: NCT04969081 — N/A
Substance Use Disorders Research Study Groups: treatment as usual, treatment as usual plus referral to work focused program
Substance Use Disorders Clinical Trial 2023: treatment as usual Highlights & Side Effects. Trial Name: NCT04969081 — N/A
treatment as usual 2023 Treatment Timeline for Medical Study. Trial Name: NCT04969081 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the enrollment capacity for this clinical trial?

"Affirmative, clinicaltrials.gov attests to this trial's pursuit of test subjects. First posted on March 1st 2022 and recently adjusted on July 1st 2022, the research is seeking 140 patients from one location."

Answered by AI

Are there any openings available for this research endeavor?

"Confirmed, according to the clinicaltrials.gov listing this trial is still open for recruitment and was originally posted on March 1st 2022 with a last update occurring July 1st of that same year."

Answered by AI

What is the purpose of this investigation?

"The objective of this 6-month medical experiment is to measure the days abstinent. Additionally, researchers will analyze changes in self-reported efficacy and esteem with New General Self-Efficacy Scale and Rosenberg Self-Esteem Scale as well as quality of life through WHOQOL BREF."

Answered by AI
~87 spots leftby Dec 2027